← Leaderboards
Bronwen Shaw
Medical College Of Wisconsin
$24,832,517
Attributed
$35,539,708
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.9M · FY2018–25$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,539,708 · 3
By mechanism
U24$35,292,162 · 2
R21$247,546 · 1
Top collaborators
- Marcelo C. Pasquini4 shared
- Amy M Moskop1 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Edgar A Deyoe$8,586,984
- Marcelo C. Pasquini$17,137,619
- Patricia Maureen Sheean$1,691,647
- Melinda R Stolley$12,155,947
- Michael J Dunn$4,004,993
Others in their field
Other Emerging Leaders on “Research Personnel”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Joel A Lipkin · Four Points Technology, Llc$178,737,225
- Lynn Briscoe · Leidos Biomedical Research, Inc.$160,201,956
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$123,112,727
Research focus
Research PersonnelResourcesInternational CenterBloodFundingBone Marrow TransplantationQuality Of LifeProgramsProspectiveNational Heart, Lung, And Blood InstituteData CollectionHematopoietic Stem Cell TransplantationCollaborationsInfrastructureCell TherapyClinical Trials NetworkPatient Outcomes AssessmentsTransplantation TherapyTransplant RecipientsClinical ResearchHematologyAmericanClinical DataEnsure
Grant awards (13)
A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research$6,714,999
U24 · FY2025 · CA · contact PI
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia$1,294,761
U24 · FY2025 · HL · contact PI
A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research$851,816
U24 · FY2025 · CA · contact PI
A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research$6,375,686
U24 · FY2024 · CA · contact PI
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia$1,190,603
U24 · FY2024 · HL · contact PI
A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research$756,884
U24 · FY2024 · CA · contact PI
A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research$6,714,997
U24 · FY2023 · CA · contact PI
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia$1,376,919
U24 · FY2023 · HL · contact PI
A Data Resource for Analyzing Blood and Marrow Transplants$4,382,188
U24 · FY2022 · CA · contact PI
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia$1,161,689
U24 · FY2022 · HL · contact PI
A Data Resource for Analyzing Blood and Marrow Transplants$4,471,620
U24 · FY2021 · CA · contact PI
Incorporating patient reported outcomes into individualized prognostication tools for survival and quality of life in transplant patients$123,773
R21 · FY2019 · HL · contact PI
Incorporating patient reported outcomes into individualized prognostication tools for survival and quality of life in transplant patients$123,773
R21 · FY2018 · HL · contact PI